Biogen Inc. buy Royal Bank of Canada
Start price
02.05.25
/
50%
€109.15
Target price
02.05.26
€181.51
Performance (%)
2.20%
Price
28.07.25
€111.55
Summary
This prediction is currently active. With a performance of 2.20%, the BUY prediction by Royal_Bank_of_Canada for Biogen Inc. is trending in the right direction. This prediction currently runs until 02.05.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | 6.289% | 6.289% |
| iShares Core DAX® | -1.165% | -0.351% |
| iShares Nasdaq 100 | 1.585% | 4.605% |
| iShares Nikkei 225® | 1.992% | -2.018% |
| iShares S&P 500 | 2.158% | 4.638% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at Royal Bank of Canada from $217.00 to $205.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat